Aquinnah Pharmaceuticals appoints two executives
Mr. Carpenter founded a number of successful biotech companies that he took public, including Integrated Genetics and GelTex Pharmaceuticals, both of which were acquired by Genzyme (now Sanofi Genzyme).
Mr. Carpenter served on the Board of Genzyme from 1994 to 2011, most recently as Lead Director.
He also founded Boston Medical Investors in 1994 and currently serves as a Director of Good Start Genetics, Olaris Therapeutics, Immuneering, Hydra Biosciences, and Lysosomal Therapeutics.
Mr. Carpenter is a graduate of West Point, Stanford University and holds an MBA from Harvard Business School.
Dr. Burnett is a medicinal chemistry leader with nearly 30 years of experience at leading pharmaceutical companies including Schering Plough, Merck and Forum.
Dr. Burnett's impressive list of awards includes: National Inventor of the Year, American Chemical Society Hero of Chemistry Award, Thomas Alva Edison Patent Award, and Prix Galien USA – Best Medical Agent Finalist.
In addition, Dr. Burnett has 60 published papers and 108 granted or published patents and applications. ■
LATEST MOVES FROM Massachusetts
- bluebird bio appoints Mary Lynne Hedley to board
- Welch's names Lesya Lysyj president, US
- Liberty Mutual appoints Gregg Cunningham as vice president
- Voyager Therapeutics appoints Matthew P. Ottmer as COO
- Ocular Therapeutix appoints Michael Goldstein as CMO
More inside POST